FR3092115B1 - analogues de GTP fluorescents et utilisation - Google Patents

analogues de GTP fluorescents et utilisation Download PDF

Info

Publication number
FR3092115B1
FR3092115B1 FR1900856A FR1900856A FR3092115B1 FR 3092115 B1 FR3092115 B1 FR 3092115B1 FR 1900856 A FR1900856 A FR 1900856A FR 1900856 A FR1900856 A FR 1900856A FR 3092115 B1 FR3092115 B1 FR 3092115B1
Authority
FR
France
Prior art keywords
fluorescent gtp
gtp analogues
fluorescent
analogues
compounds
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
FR1900856A
Other languages
English (en)
Other versions
FR3092115A1 (fr
Inventor
Laurent Lamarque
Emmanuel Bourrier
Thomas Roux
Eric Trinquet
Elodie Dupuis
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cisbio Bioassays SAS
Original Assignee
Cisbio Bioassays SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to FR1900856A priority Critical patent/FR3092115B1/fr
Application filed by Cisbio Bioassays SAS filed Critical Cisbio Bioassays SAS
Priority to JP2021544495A priority patent/JP2022523322A/ja
Priority to CN202080018205.6A priority patent/CN113490678A/zh
Priority to CA3127857A priority patent/CA3127857A1/fr
Priority to EP20707504.5A priority patent/EP3917941A1/fr
Priority to US17/427,200 priority patent/US20220144860A1/en
Priority to PCT/FR2020/050149 priority patent/WO2020157439A1/fr
Publication of FR3092115A1 publication Critical patent/FR3092115A1/fr
Application granted granted Critical
Publication of FR3092115B1 publication Critical patent/FR3092115B1/fr
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H23/00—Compounds containing boron, silicon, or a metal, e.g. chelates, vitamin B12
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F5/00—Compounds containing elements of Groups 3 or 13 of the Periodic System

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biotechnology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Saccharide Compounds (AREA)

Abstract

Analogues de GTP fluorescents et utilisation L’invention concerne des composés de formule : (I) dans laquelle X, Y, L et Ln3+ sont tels que définis dans la description.
FR1900856A 2019-01-30 2019-01-30 analogues de GTP fluorescents et utilisation Active FR3092115B1 (fr)

Priority Applications (7)

Application Number Priority Date Filing Date Title
FR1900856A FR3092115B1 (fr) 2019-01-30 2019-01-30 analogues de GTP fluorescents et utilisation
CN202080018205.6A CN113490678A (zh) 2019-01-30 2020-01-30 荧光gtp类似物和用途
CA3127857A CA3127857A1 (fr) 2019-01-30 2020-01-30 Analogues de gtp fluorescents et utilisation
EP20707504.5A EP3917941A1 (fr) 2019-01-30 2020-01-30 Analogues de gtp fluorescents et utilisation
JP2021544495A JP2022523322A (ja) 2019-01-30 2020-01-30 蛍光ｇｔｐ類似体および使用
US17/427,200 US20220144860A1 (en) 2019-01-30 2020-01-30 Fluorescent gtp analogues and use
PCT/FR2020/050149 WO2020157439A1 (fr) 2019-01-30 2020-01-30 Analogues de gtp fluorescents et utilisation

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR1900856A FR3092115B1 (fr) 2019-01-30 2019-01-30 analogues de GTP fluorescents et utilisation
FR1900856 2019-01-30

Publications (2)

Publication Number Publication Date
FR3092115A1 FR3092115A1 (fr) 2020-07-31
FR3092115B1 true FR3092115B1 (fr) 2021-11-12

Family

ID=66867435

Family Applications (1)

Application Number Title Priority Date Filing Date
FR1900856A Active FR3092115B1 (fr) 2019-01-30 2019-01-30 analogues de GTP fluorescents et utilisation

Country Status (7)

Country Link
US (1) US20220144860A1 (fr)
EP (1) EP3917941A1 (fr)
JP (1) JP2022523322A (fr)
CN (1) CN113490678A (fr)
CA (1) CA3127857A1 (fr)
FR (1) FR3092115B1 (fr)
WO (1) WO2020157439A1 (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US11591361B2 (en) 2020-12-29 2023-02-28 Microsoft Technology Licensing, Llc Linker structures with minimal scar for enzymatic synthesis
EP4272000A2 (fr) * 2020-12-29 2023-11-08 Microsoft Technology Licensing LLC Structures de lieur à cicatrice minimale pour synthèse enzymatique
EP4089413A1 (fr) 2021-05-12 2022-11-16 Cisbio Bioassays Procédé de détermination de la liaison d'un anticorps au composant du complément 1q (c1q)
CN116375780B (zh) * 2023-06-02 2023-08-15 山东大学 一种用于识别gtp结合蛋白的光亲和探针及其制备方法和应用

Family Cites Families (31)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE8502573D0 (sv) 1985-05-23 1985-05-23 Jouko Kanakre Fluorescent lanthanide chelates useful as labels of physiologically active materials
US5696240A (en) 1991-03-15 1997-12-09 Vallarino; Lidia M. Macrocyclic complexes of yttrium, the lanthanides and the actinides having peripheral coupling functionalities
US5571897A (en) 1991-12-05 1996-11-05 Wallac Oy Luminescent lanthanide chelates
US5859215A (en) 1995-10-25 1999-01-12 Wallac Oy Biospecific binding reactants labelled with luminescent lanthanide chelates and their use
US6211354B1 (en) 1998-05-06 2001-04-03 Tosch Corporation Optically active DNA probe having phosphonic diester linkage
FR2810406B1 (fr) 2000-06-15 2002-09-20 Cis Bio Int Nouveaux cryptates de terre rare peu sensibles a l'extinction de fluorescence
AU2002322416A1 (en) 2001-07-06 2003-03-03 Board Of Trustees Of The University Of Illinois Gfp fusion proteins and their use
AU2003211865A1 (en) 2002-03-08 2003-09-22 Mitsubishi Rayon Co., Ltd. Novel fluorescent label compounds
US20090186343A1 (en) 2003-01-28 2009-07-23 Visigen Biotechnologies, Inc. Methods for preparing modified biomolecules, modified biomolecules and methods for using same
GB0421693D0 (en) 2004-09-30 2004-11-03 Amersham Biosciences Uk Ltd Method for measuring binding of a test compound to a G-protein coupled receptor
EP1794237A2 (fr) 2004-09-30 2007-06-13 GE Healthcare UK Limited Analogues de nucleotides fluorescents
WO2006086883A1 (fr) 2005-02-16 2006-08-24 Universite De Montreal Biocapteurs permettant de surveiller l'activation de la proteine g induite par un recepteur
EP1885817B1 (fr) 2005-05-11 2016-05-11 University Of Durham Complexes de lanthanide a reponse luminescente
US20080091005A1 (en) 2006-07-20 2008-04-17 Visigen Biotechnologies, Inc. Modified nucleotides, methods for making and using same
CA2660800C (fr) 2006-08-15 2016-03-01 The Regents Of The University Of California Complexes de lanthanides macrocycliques luminescents
WO2008025886A1 (fr) 2006-09-01 2008-03-06 Wallac Oy Chélates métalliques et agents de chélation contenant des sous-motifs triazolyle
GB2451106A (en) 2007-07-18 2009-01-21 Cis Bio Int Lanthanide (III) ion complexing pyrazoyl-aza(thio)xanthone comprising compounds, their complexes and their use as fluorescent labels
JP5711966B2 (ja) * 2007-08-01 2015-05-07 ザ ジェネラル ホスピタル コーポレイション Ｇタンパク質共役受容体および関連組成物を使用するスクリーニング方法
FI20070926A0 (fi) 2007-11-30 2007-11-30 Wallac Oy Transportterimääritys
US20110165652A1 (en) 2008-01-14 2011-07-07 Life Technologies Corporation Compositions, methods and systems for single molecule sequencing
FR2940286B1 (fr) 2008-12-19 2011-04-08 Cis Bio Int Nouveaux cryptates de terres rares comportant un motif tetraazatriphenylene
GB2467012A (en) 2009-01-20 2010-07-21 Cis Bio Int Lanthanide (III) ion complexing compounds, luminescent lanthanide (III) ion complexes and use thereof as fluorescent labels
CN102300861B (zh) * 2009-02-03 2015-07-01 百奥提姆股份有限公司 包含磺酰胺基团的呫吨染料
WO2012150866A1 (fr) 2011-05-03 2012-11-08 Industrial Research Limited Inhibiteurs de phosphoribosyltransférases et leurs utilisations
FR2978149B1 (fr) 2011-07-18 2014-01-10 Cisbio Bioassays Nouveaux agents complexants et complexes de lanthanide correspondant, et leur utilisation comme marqueurs luminescents
FR3000960B1 (fr) 2013-01-16 2015-03-06 Cisbio Bioassays Nouveaux agents complexants hydrosolubles et complexes de lanthanide correspondants
AU2015369722A1 (en) 2014-12-22 2017-08-03 Lumiphore, Inc. Functionalized linear ligands and complexes thereof
FR3045053B1 (fr) 2015-12-09 2018-01-05 Cisbio Bioassays Agents complexants hydrosolubles a base de triazapyridinophane et complexes de lanthanide fluorescents correspondants
WO2018022932A1 (fr) 2016-07-27 2018-02-01 Uncorked Studios Incorporated Système et procédés de gestion d'inventaire de vin
CA3035526A1 (fr) 2016-09-02 2018-03-08 Lumiphore, Inc. Ligands macrocycliques ayant des fractions chelatantes pendantes et leurs complexes
FR3067349B1 (fr) 2017-06-12 2020-12-04 Cisbio Bioassays Nouveaux agents mono et di-antennes complexants hydrosolubles et complexes de lanthanide correspondants

Also Published As

Publication number Publication date
JP2022523322A (ja) 2022-04-22
WO2020157439A1 (fr) 2020-08-06
CN113490678A (zh) 2021-10-08
EP3917941A1 (fr) 2021-12-08
US20220144860A1 (en) 2022-05-12
CA3127857A1 (fr) 2020-08-06
FR3092115A1 (fr) 2020-07-31

Similar Documents

Publication Publication Date Title
FR3092115B1 (fr) analogues de GTP fluorescents et utilisation
MA42678B1 (fr) Nouveaux analogues nucléosidiques substitués à cycle aromatique bicyclique 6-6 pour une utilisation en tant qu'inhibiteurs de prmt5
MA42109A (fr) Amides hétérocycliques utilisés en tant qu'inhibiteurs de kinase
MA55131B1 (fr) Nouveaux composés hétérocycliques
MA39211B1 (fr) Composés tricycliques comme agents anti-cancers
MA35342B1 (fr) Composés de-pipéridinyle utiles comme inhibiteurs de la tankyrase
CY1117681T1 (el) Ρυθμιστες 2,3-διοξυγενασης ινδολοαμινης και μεθοδοι χρησης αυτων
MA42795A (fr) Composés thérapeutiques utiles pour le traitement prophylactique ou thérapeutique d'une infection par le virus du vih
MA39193B1 (fr) Modulateurs du gpr6 à base de tétrahydropyridopyrazines
MA31906B1 (fr) Inhibiteurs de la replication du virus de limmunodeficience humaine
MA34361B1 (fr) Dérivés de tétrahydro-pyrido-pyrimidine
MA37959A2 (fr) Dérivés de 5-phénoxy-3h-pyrimidin-4-one et leur utilisation en tant qu'inhibiteurs de la transcriptase inverse du vih
MA51669B1 (fr) Modulateurs de tmem16a
MA40290A1 (fr) Agents immunorégulateurs
MA35869B1 (fr) Composés imidazopyrrolidinone
MA40281B1 (fr) Composés de pyrazole et leur utilisation en tant qu' agents de blocage des canaux calciques de type t
MA54386B1 (fr) Modulateurs de trex1
MA35100B1 (fr) Analogues de l'acide époxyéicosatriénoïque et leurs procédés de fabrication et d'utilisation
EA200970132A1 (ru) Аналоги морфолинила и пирролидинила
MA39152A1 (fr) Cyclopentanes substitués en 1,2 utilisés comme antagonistes du récepteur d'orexine
MA38410B1 (fr) Composés d'azétidinyloxyphénylpyrrolidine
EA201791667A1 (ru) Соединения бензоксаборола и их применение
MA31526B1 (fr) Nouveaux herbicides
EA200602049A1 (ru) Пролекарства стероидов с андрогенным действием
MA35742B1 (fr) Dérivés de n- (4 -quinolinylmethyl) sulfonamide et leur utilisation en tant qu'antihelminthiques

Legal Events

Date Code Title Description
PLFP Fee payment

Year of fee payment: 2

PLSC Publication of the preliminary search report

Effective date: 20200731

PLFP Fee payment

Year of fee payment: 3

PLFP Fee payment

Year of fee payment: 4

PLFP Fee payment

Year of fee payment: 5

PLFP Fee payment

Year of fee payment: 6